Zepbound is the name of the first drug approved by the FDA for obstructive sleep apnea. According to the Mayo Clinic, obstructive sleep apnea is a common sleep-related breathing disorder that occurs ...

Mayo Clinic doctors tap into AI technology to detect and treat women with sleep apnea, a disorder that's often misdiagnosed ...

The weight-loss drug Zepbound (tirzepatide) now has another major benefit: on Dec. 20, it became the first drug approved by the U.S. Food and Drug Administration (FDA) to treat obstructive sleep apnea ...

ROCHESTER, Minn. — Mayo Clinic researchers have developed an artificial intelligence algorithm capable of diagnosing ...

GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better manage their type 2 diabetes. And as of December 20, Eli Lilly’s weight loss ...

Obstructive sleep apnea or OSA affects nearly a billion people across the globe. It robs people of their sleep — they stop breathing sometimes 20 to 50 to 100 times a night and are abruptly awakened.

Weight loss pills and injections are often touted as miracle drugs. Research shows that they can help you lose weight, better help you manage type II diabetes, and even reduce your risk of heart ...

INDIANAPOLIS (WISH) — Obstructive sleep apnea or OSA affects nearly a billion people across the globe. It robs people of their sleep — they stop breathing sometimes 20 to 50 to 100 times a night and ...

Weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, a new study says. Type 2 diabetes patients taking GLP-1 drugs were overall less likely ...

Rochester, Minn.-based Mayo Clinic has developed an AI algorithm that can detect obstructive sleep apnea using electrocardiogram results. The study, published Nov. 4 in JACC: Advances, analyzed ...

Studies show that women aren't getting enough sleep. There is a medical reason: an underdiagnosis of sleep apnea in women ...